Nuvation Bio Inc - Ordinary Shares - Class A Live Stock Price Today, Share Analysis and Chart

Name: Nuvation Bio Inc - Ordinary Shares - Class A: Is Infosys Ltd. worth buying?
Item: Nuvation Bio Inc - Ordinary Shares - Class A
Rating: 2.00908325
Author: Trendlyne DVM scores

about

Nuvation Bio Inc is a biopharmaceutical company tackling unmet needs in oncology by developing differentiated and novel therapeutic candidates. Its product candidate, taletrectinib, is an oral, potent, central nervous system-active, selective, next-g...

4.98 0.34 (7.33%)

223.38% Gain from 52W Low

4.9M

XNYS Volume

XNYS 11 Nov, 2025 4:30 PM (EST)

Board Meeting

The next board meeting for Nuvation Bio Inc - Ordinary Shares - Class A is on 19 Nov 2025 for the purpose of Jefferies Global Healthcare Conference See details

Not Eligible

Expensive Valuation

9.8 / 100

Technically Bullish

70.5 / 100

1Yr Price target upside is 74%

6 analysts

Nuvation Bio Inc Ordinary Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Nuvation Bio Inc - Ordinary Shares - Class A Live Stock Price Today, Share Analysis and Chart

Nuvation Bio Inc is a biopharmaceutical company tackling unmet needs in oncology by developing differentiated and novel therapeutic candidates. Its product candidate, taletrectinib, is an oral, potent, central nervous system-active, selective, next-g...

223.38% Gain from 52W Low

SWOT Analysis

Nuvation Bio Inc Ordinary Live Price Chart